• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dime Bancorp

Dime Bancorp

  1. EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME )

    EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema ( DME )

  2. pSivida Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for Reimbursement in Portugal

    pSivida Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for Reimbursement in Portugal

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.